Norlase Announces New Distributors in Multiple Global Regions

Norlase •  DECEMBER 13, 2022  •  news

    

Norlase Announces New Distributors in Multiple Global Regions

Norlase •  DECEMBER 13, 2022  •  news

    

Ballerup, Denmark and Redwood City, CA, USA – December 13, 2022 – Norlase, an emerging global ophthalmic laser manufacturer developing next-generation laser solutions, is pleased to announce the expansion of its global distribution network in several markets, including the Americas, Asia-Pacific, Europe and the Middle East. Norlase is the developer and manufacturer of the LEAF, LION, and pattern-scanning ECHO, the world’s most portable ophthalmic lasers offering ophthalmologists unprecedented flexibility and practice efficiency. These systems are already in use at globally-recognized ophthalmic care institutions, such as Bascom Palmer Institute and Wills Eye Hospital.

“Developing cutting-edge technology only matters if people have access to it,” said Oliver Hvidt, CEO and President of Norlase. “As we approach 2023, we’re proud to partner with a new set of distributors to bring more doctors the solutions they need to efficiently treat patients.”

Countries that are part of the most recent expansion include Ecuador, Bangladesh, Nepal, Pakistan, Israel, Sweden, and Switzerland.

What Our Regional Leaders Are Saying

“We are thrilled to welcome new distribution partners into the fold, and continue the excellent momentum seen in 2022,” said Douglas Cheah, Regional Director, Asia-Pacific.

“The recent launch of the Norlase ECHO has excited customers in our local markets, and we’re equally excited to deliver the disruptive technology they need,” said Guillermo Molina, Regional Director, LACA.

“Norlase is proud to welcome a new group of partners into our distribution family. We are on a mission to change ophthalmic care for the better, and every trusted partner helps us advance that mission,” said Taoufiq Jellal, VP of Distribution.

In 2023, Norlase will continue its efforts to grow into additional global markets, with the goal of making its innovative clinical technology available to every ophthalmologist. For more information on Norlase’s global network, please visit our Distributor page.

About Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION, the first fully integrated green laser and LIO; and ECHO, the world’s first ultra-portable pattern scanning laser. Learn more at norlase.com.

Ballerup, Denmark and Redwood City, CA, USA – December 13, 2022 – Norlase, an emerging global ophthalmic laser manufacturer developing next-generation laser solutions, is pleased to announce the expansion of its global distribution network in several markets, including the Americas, Asia-Pacific, Europe and the Middle East. Norlase is the developer and manufacturer of the LEAF, LION, and pattern-scanning ECHO, the world’s most portable ophthalmic lasers offering ophthalmologists unprecedented flexibility and practice efficiency. These systems are already in use at globally-recognized ophthalmic care institutions, such as Bascom Palmer Institute and Wills Eye Hospital.

“Developing cutting-edge technology only matters if people have access to it,” said Oliver Hvidt, CEO and President of Norlase. “As we approach 2023, we’re proud to partner with a new set of distributors to bring more doctors the solutions they need to efficiently treat patients.”

Countries that are part of the most recent expansion include Ecuador, Bangladesh, Nepal, Pakistan, Israel, Sweden, and Switzerland.

What Our Regional Leaders Are Saying

“We are thrilled to welcome new distribution partners into the fold, and continue the excellent momentum seen in 2022,” said Douglas Cheah, Regional Director, Asia-Pacific.

“The recent launch of the Norlase ECHO has excited customers in our local markets, and we’re equally excited to deliver the disruptive technology they need,” said Guillermo Molina, Regional Director, LACA.

“Norlase is proud to welcome a new group of partners into our distribution family. We are on a mission to change ophthalmic care for the better, and every trusted partner helps us advance that mission,” said Taoufiq Jellal, VP of Distribution.

In 2023, Norlase will continue its efforts to grow into additional global markets, with the goal of making its innovative clinical technology available to every ophthalmologist. For more information on Norlase’s global network, please visit our Distributor page.

About Norlase

Norlase develops next-generation laser solutions for the treatment of retina and glaucoma diseases. Founded in Denmark, Norlase is made up of worldwide industry experts in ophthalmology, laser technology, medical device development, and customer care. Norlase is on a mission to improve practice efficiency, patient care, and physician convenience for ophthalmologists worldwide. Norlase products include LEAF, a laser photocoagulator that’s 10x smaller than existing systems and mounts directly on the slit lamp; LION, the first fully integrated green laser and LIO; and ECHO, the world’s first ultra-portable pattern scanning laser. Learn more at norlase.com.

DIDN’T FIND WHAT YOU’RE LOOKING FOR?

Let us know how we can help!

DIDN’T FIND WHAT YOU
WERE LOOKING FOR?

Let us know how we can help!